While immunopathology has been widely studied in patients with severe COVID-19, immune responses in non-hospitalized patients have remained largely elusive. We systematically analyze 484 peripheral cellular or soluble immune features in a longitudinal cohort of 63 mild and 15 hospitalized patients versus 14 asymptomatic and 26 household controls. We observe a transient increase of IP10/CXCL10 and interferon-β levels, coordinated responses of dominant SARS-CoV-2-specific CD4 and fewer CD8 T cells, and various antigen-presenting and antibody-secreting cells in mild patients within 3 days of PCR diagnosis. The frequency of key innate immune cells and their functional marker expression are impaired in hospitalized patients at day 1 of inclusion...
SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which remains ill defin...
Abstract While some individuals infected by severe acute respiratory syndrome coronavirus 2 (SARS-Co...
The kinetics of the immune changes in COVID-19 across severity groups have not been rigorously asses...
peer reviewedWhile immunopathology has been widely studied in patients with severe COVID-19, immune ...
COVID-19 differs substantially between individuals, ranging from mild to severe or even fatal. Heter...
COVID-19 differs substantially between individuals, ranging from mild to severe or even fatal. Heter...
The kinetics of the immune changes in COVID-19 across severity groups have not been rigorously asses...
The kinetics of the immune changes in COVID-19 across severity groups have not been rigorously asses...
The kinetics of the immune changes in COVID-19 across severity groups have not been rigorously asses...
The kinetics of the immune changes in COVID-19 across severity groups have not been rigorously asses...
SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which remains ill-defin...
SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which remains ill defin...
SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which remains ill defin...
COVID-19, the disease caused by SARS-CoV-2 infection, can assume a highly variable disease course, r...
SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which remains ill defin...
SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which remains ill defin...
Abstract While some individuals infected by severe acute respiratory syndrome coronavirus 2 (SARS-Co...
The kinetics of the immune changes in COVID-19 across severity groups have not been rigorously asses...
peer reviewedWhile immunopathology has been widely studied in patients with severe COVID-19, immune ...
COVID-19 differs substantially between individuals, ranging from mild to severe or even fatal. Heter...
COVID-19 differs substantially between individuals, ranging from mild to severe or even fatal. Heter...
The kinetics of the immune changes in COVID-19 across severity groups have not been rigorously asses...
The kinetics of the immune changes in COVID-19 across severity groups have not been rigorously asses...
The kinetics of the immune changes in COVID-19 across severity groups have not been rigorously asses...
The kinetics of the immune changes in COVID-19 across severity groups have not been rigorously asses...
SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which remains ill-defin...
SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which remains ill defin...
SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which remains ill defin...
COVID-19, the disease caused by SARS-CoV-2 infection, can assume a highly variable disease course, r...
SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which remains ill defin...
SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which remains ill defin...
Abstract While some individuals infected by severe acute respiratory syndrome coronavirus 2 (SARS-Co...
The kinetics of the immune changes in COVID-19 across severity groups have not been rigorously asses...